IGM Biosciences Net Income

IGM Biosciences (IGMS) currently reports a net income of $-53M as of June 2025. That compares with $-220M in the prior-year period — up 75.8% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore IGM Biosciences's net income history and peer comparisons.

IGM Biosciences's net income increased from $-220M to $-53M — a 75.8% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

IGM Biosciences's net income of $-53M is lower than the Healthcare sector average of $16B. That is roughly 100.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

IGM Biosciences reported $-53M in net income as of June 2025. That compares with $-220M in the prior-year period — up 75.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-53M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for IGM Biosciences, and consider following IGMS for alerts when major investors trade the stock.